Advanced Search
ZHANG Zhengzheng, TANG Luying, LIN Ying, SU Fengxi, WU Banghua, REN Zefang. Association between Urinary Molybdenum and Risk of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1205-1208. DOI: 10.3971/j.issn.1000-8578.2014.11.010
Citation: ZHANG Zhengzheng, TANG Luying, LIN Ying, SU Fengxi, WU Banghua, REN Zefang. Association between Urinary Molybdenum and Risk of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(11): 1205-1208. DOI: 10.3971/j.issn.1000-8578.2014.11.010

Association between Urinary Molybdenum and Risk of Breast Cancer

More Information
  • Received Date: September 04, 2013
  • Revised Date: November 24, 2013
  • Objective To explore the association between urinary molybdenum and the risk of breast cancer. Methods Questionnaire survey and urine sample collection were applied on 240 female breast cancer patients and 246 healthy and age-matched controls in two Affiliated Hospitals of Sun Yat-sen University from Oct. 2009 to July 2010. Rank test and multivariate analysis were used to estimate the association between urinary molybdenum and risk of breast cancer. Results Creatinine-adjusted urine levels of molybdenum (median μg/g) were 85.20 μg/g in female breast cancer patients and 72.68 μg/g in the controls, with statistically significant difference. There was a tendency that the intermediate tertile was associated with a lower risk of breast cancer while the highest tertile increased the risk of breast cancer, compared with the lowest tertile, with no statistical significance. Postmenopausal women in the highest tertile of urine molybdenum showed a significant increased risk of breast cancer, compared with those in the lowest tertile (OR=2.35, 95%CI=1.13-4.92). Conclusion A moderate level of Molybdenum may have inhibitory effect of breast cancer; while a high level of Molybdenum may increase the risk of breast cancer, especially for postmenopausal women.
  • [1]
    Parkin DM, Bray F, Ferlay J, et al. Global cancaer statistics, 20 02[J]. CA Cancer J Clin, 2005, 55(2): 74-108.
    [2]
    Rajagopalan KV. Molybdenum: an essential trace element in human nutrition[J]. Annu Rev Nutr, 1988, 8: 401-27.
    [3]
    Bandarra D, Lopes M, Lopes T, et al. Mo(II) complexes: a new family of cytotoxic agents? [J]. J Inorg Biochem, 2010, 104(11): 11 71-7.
    [4]
    Lu XM, Lu JF, Mao XA. Crystal structure and EPR spectra of cis‐dioxo‐molybdenum (V) complex with o‐aminophenol[J]. Chin J Chem, 2002, 20(6): 617-21.
    [5]
    Nakadaira H, Endoh K, Yamamoto M, et al. Distribution of selenium and molybdenum and cancer mortality in Niigata, Japan[J]. Arch Environ Health, 1995, 50(5): 374-80.
    [6]
    Nouri M, Chalian H, Bahman A, et al. Nail molybdenum and zinc contents in populations with low and moderate incidence of esophageal cancer[J]. Arch Iran medicine, 2008, 11(4): 392-6.
    [7]
    Zeng ZH, Zeng XP. Cancer and soil Mo in China[J].Nong Cun Sheng Tai Huan Jing,2000,16(2):60-1.[曾昭华, 曾雪萍. 中国癌 症与土壤中钼元素的关系[J]. 农村生态环境, 2000, 16(2): 60-1].
    [8]
    Jia RB. New progress of molybdenum and gastric cancer[J]. Zhongguo Mu Ye, 2000,24(1):46-9.[贾如宝. 钼元素与胃癌研究 新进展[J]. 中国钼业, 2000, 24(1): 46-9].
    [9]
    Wei HJ, Luo XM, Yang XP. The effect of Molybdenum and tungsten on breast cancer of SD rats[C]//.Chinese Nutrition Society Symposuim on Trace Elements in the First Complation of Abstracts, 1985:39-40.[魏慧娟, 罗贤懋, 杨湘平. 钼和钨对 SD 大鼠乳腺癌的影响[C]//中国营养学会首届微量元素专题讨论 会论文摘要汇编, 1985:39-40].
    [10]
    Guo XY, Chen SW, Zheng AM. The association between trace elemets and breast cancer[J].Shanxi Yi Xue Za Zhi,1992,21(6):371-3. [郭先予, 陈松旺, 郑爱民. 微量元素与乳 腺癌的关系[J]. 陕西医学杂志, 1992, 21(6): 371-3].
    [11]
    Gangnon R, McElroy J. Heavy metal exposure and breast cancer risk[EB/OL]. [2007]. http://cbe.wisc.edu/assets/docs/pdf/srpbio/ 20 07/Crouch.pdf
    [12]
    Novotny JA, Turnlund JR. Molybdenum intake influences molybdenum kinetics in men[J]. J Nutr, 2007, 137(1): 37-42.
    [13]
    Su Y, Chen LJ, He JR, et al. Urinary rubidium in breast cancers[J]. Clin Chim Acta, 2011, 412(23-24): 2305-9.
    [14]
    Chen BY. The ant i - c anc e r e ff e c t s of t r a c e e l ement s molybdenum[J]. Wei Liang Yuan Su Yu Jian Kang Yan Jiu, 20 08,25(2):68-69. [陈伯扬. 微量元素钼的抗癌作用[J]. 微量元 素与健康研究, 2008, 25(2): 68-9].
    [15]
    Sardesai VM. Molybdenum: an essential trace element[J]. Nutr Clin Pract, 1993, 8(6): 277- 81.
    [16]
    Lupulescu A. Estrogen use and cancer incidence: a review[J]. Cancer Invest, 1995, 13(3): 287-95.
    [17]
    Kimble R, Srivastava S, Bellone C, et al. Estrogen inhibits IL-1 and TNF gene expression in transfected murine macrophagic cells[J]. J Bone Miner Res,1996,11(Suppl 1):235.
    [18]
    Wright RM, McManaman JL. The role of molybdenum hydroxylase generated free radicals in alcohol induced breast cancer[EB/OL]. [2002].http://oai.dtic.mil/oai/oai?verb=getRecord &metadataPrefix=html&identifier=ADA410290.
    [19]
    Pritsos CA. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system[J]. Chem Biol Interact, 20 00, 129(1-2): 195-208.
    [20]
    Centers for Disease Control and Prevention. Third national report on human exposure to environmental chemicals[EB/OL]. Atlanta: CDC, 2005. http://www.cdc.gov/exposurereport.
    [21]
    Yoshida M, Hattori H, Ôta S, et al. Molybdenum balance in healthy young Japanese women[J]. J Trace Elem Med Biol, 2006, 20 (4): 245-52.
    [22]
    Scott L, Nguyen L, Harris M. Referent levels of urinary antimony, barium, cesium, and molybdenum concentrations in the U.S. population[J]. Epidemiology, 2008, 19(6): S366-S7.
    [23]
    Hnizdo E, Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence[J]. Occup Environ Med, 2003, 60(4): 237-43.
    [24]
    Turnlund JR, Keyes WR, Peiffer GL, et al. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men during depletion and repletion[J]. Am J Clin Nutr, 19 95, 61(5): 1102-9.
  • Related Articles

    [1]XIE Liang, LIU Chang, LI Jianhua, LI Jianhui, HAO Xin, HUA Haiyang. Risk Factor and Risk Prediction Modeling of Rectal Neuroendocrine Tumors[J]. Cancer Research on Prevention and Treatment, 2025, 52(7): 598-604. DOI: 10.3971/j.issn.1000-8578.2025.24.1089
    [2]QIAO Yihuan, LI Jipeng, CHEN Le, DU Zhenghua, GUO Yuan. Risk Factors of Vascular Invasion in Patients with Resectable Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(2): 123-127. DOI: 10.3971/j.issn.1000-8578.2022.21.0565
    [3]LIU Ying, ZHANG Hongping, YANG Hongying, GUI Yanli. Risk Factor of Intestinal Obstruction After Radical Surgery of Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2018, 45(6): 391-394. DOI: 10.3971/j.issn.1000-8578.2018.17.1291
    [4]XIE Zhaoyun, QIN Jialu, XIONG Yun, LIU Liang, WEI Hua. Risk Factors for Death of Advanced Lung Cancer Patients with Lung Infection[J]. Cancer Research on Prevention and Treatment, 2018, 45(4): 221-224. DOI: 10.3971/j.issn.1000-8578.2018.17.0993
    [5]ZHANG Yachen, LIANG Di, JIN Jing, LI Daojuan, LIU Congmin, GAO Zhaoyu, HE Yutong. Research Progress on Risk Factors for Lung Cancer in Nonsmokers[J]. Cancer Research on Prevention and Treatment, 2017, 44(7): 501-505. DOI: 10.3971/j.issn.1000-8578.2017.16.1627
    [6]ZHANG Jie, LI Shufen, SHI Yehui, HAO Chunfang, DONG Guolei, TONG Zhongsheng. Risk Factors for Brain Metastases from Advanced Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 447-451. DOI: 10.3971/j.issn.1000-8578.2014.05.023
    [7]Xu Youxian, Yuan Lin, Chen Guangli. Incidence and Risk Factors of Cervical Lesions among Different Famale People[J]. Cancer Research on Prevention and Treatment, 2012, 39(11): 1379-1381. DOI: 10.3971/j.issn.1000-8578.2012.11.025
    [8]ZHENG Ling-ling, CAI Lin. Case-control Study of Risk Factors for Lung Cancer among Nonsmokers[J]. Cancer Research on Prevention and Treatment, 2011, 38(11): 1306-1310. DOI: 10.3971/j.issn.1000-8578.2011.11.023
    [9]PENG Xian-e, JIANG Ying-ying, SHI Xi-shun, ZHENG Xiao-yian, XIAO Jing-rong, LIN Xu. Case-control Study on Risk Factors of Colorectal Cancer in Fujian Province[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 794-796. DOI: 10.3971/j.issn.1000-8578.2009.09.023
    [10]ZENG Zhuan-ping, CHEN Feng, LIU Bin, HUANG Man-ni, ZHANG Xun, PAN Qin-jing, ZHAO Fang-hui, RONG Shou-de, QIAO You-lin. Analysis of Risk Factors for Cervical Cancer in Yangcheng County[J]. Cancer Research on Prevention and Treatment, 2004, 31(03): 178-181. DOI: 10.3971/j.issn.1000-8578.1020

Catalog

    Article views (1668) PDF downloads (318) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return